🟡 60/100

Review before taking

  • Zinc: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Zinc: 50mg is 1.2× the Tolerable Upper Intake Level (40mg)

This product received a low score because its 50mg zinc content exceeds the recommended maximum daily limit of 40mg.

Label Data

1 Tablet(s) Serving Size
100 Servings
Mineral Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

50 mg (333% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.2× (UL: 40 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 50mg UL 40mg

Other Ingredients

Cellulose Stearin Cellulose Gum Modified Cellulose Dicalcium Phosphate Silica Magnesium Stearate

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (78% of products) Nutrient (56% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, adults take one (1) tablet daily with meals, or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

🧪 Formulation Notes

Contains no sugar, salt, dairy, yeast, soy, wheat, gluten, preservatives, artificial colors or flavors.

Quality & potency guaranteed

Additional Information

Store in a cool, dry place and away from direct light.

Product Details

DSLD Entry Date 2024-07-25
Product Type Mineral
Form Tablet or Pill
DSLD ID 316665
Data Updated 2026-04-11

Research Evidence

50 Research Sources
47 Avg Quality Score
28 Rct
13 Clinical Trial
5 Guideline
4 Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020
View all evidence for Tyrosine →

Compare Similar Products

View all Tyrosine products →